HKSE - Delayed Quote HKD
Shandong Boan Biotechnology Co., Ltd. (6955.HK)
10.000
-0.620
(-5.84%)
At close: May 6 at 4:08:32 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
726,316
726,316
618,129
515,960
158,704
Cost of Revenue
183,663
183,663
209,161
161,730
52,190
Gross Profit
542,653
542,653
408,968
354,230
106,514
Operating Expense
438,158
438,158
513,134
680,457
323,516
Operating Income
104,495
104,495
-104,166
-326,227
-217,002
Net Non Operating Interest Income Expense
-32,246
-32,246
-12,928
-7,839
-2,498
Pretax Income
73,189
73,189
-119,377
-331,749
-225,417
Net Income Common Stockholders
73,189
73,189
-119,377
-331,749
-225,417
Diluted NI Available to Com Stockholders
73,189
73,189
-119,377
-331,749
-225,417
Basic EPS
0.12
0.14
-0.23
-0.67
-0.44
Diluted EPS
0.12
0.14
-0.23
-0.67
-0.44
Basic Average Shares
509,278.094
535,933.694
509,278.094
498,612.595
509,278.094
Diluted Average Shares
509,278.094
535,933.694
509,278.094
498,612.595
509,278.094
Rent Expense Supplemental
--
--
4,128
4,491
--
Total Expenses
621,821
621,821
722,295
842,187
375,706
Net Income from Continuing & Discontinued Operation
73,189
73,189
-119,377
-331,749
-225,417
Normalized Income
73,189
73,189
-119,377
-331,749
-225,417
Interest Income
405
405
1,159
5,568
9,101
Interest Expense
32,651
32,651
14,087
13,407
11,599
Net Interest Income
-32,246
-32,246
-12,928
-7,839
-2,498
EBIT
105,840
105,840
-105,290
-318,342
-213,818
EBITDA
178,745
178,745
-22,524
-245,507
-163,809
Reconciled Cost of Revenue
183,663
183,663
209,161
161,730
52,190
Reconciled Depreciation
72,905
72,905
82,766
72,835
50,009
Net Income from Continuing Operation Net Minority Interest
73,189
73,189
-119,377
-331,749
-225,417
Normalized EBITDA
178,745
178,745
-22,524
-245,507
-163,809
12/31/2021 - 12/30/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade